insights_auto
Why is EDIT up 13,46%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,95 US$
arrow_upward
+13,46%(+0,35) 1D
2,86 US$
arrow_downward
-2,99% (-0,088)bedtimeAfter hours
Closed: 28 ოქტ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,59 US$
High
2,96 US$
Low
2,54 US$
Mkt. cap
453,06 მლნ.
Avg. vol.
2,91 მლნ.
Volume
4,43 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
Open
2,59 US$
High
2,96 US$
Low
2,54 US$
Mkt. cap
453,06 მლნ.
Avg. vol.
2,91 მლნ.
Volume
4,43 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
News stories
From web sources and news partners
Reuters
·
1 საათის წინ
Asian shares fall as Alphabet earnings miss drags Wall St futures lower
TradingView
·
1 საათის წინ
Janus Henderson Launches Tokenized Nasdaq-100 Fund JQQQ on Stellar
Yahoo Finance
·
1 საათის წინ
Dow, S&P 500, Nasdaq Futures Mixed After Fed Holds Rates Steady: GOOG, GOOGL, IOVA, MSFT, NOW In Focus
Investor's Business Daily
·
1 საათის წინ
Tech Futures Fall On Google, These Huge Losers
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc